Literature DB >> 8989213

Retroviral coinfections at a New Orleans HIV outpatient clinic.

R Bessinger1, M Beilke, P Kissinger, C Jarrott, O F Tabak.   

Abstract

The purpose of the study was to determine the seroprevalence of human T-lymphotropic virus types I and II (HTLV-I and HTLV-II) infections in an outpatient clinic population of human immunodeficiency virus (HIV)-1 infected persons as well as to identify the demographic and clinical characteristics and laboratory results associated with HTLV-I/II infections. During 1993-1995, 854 patients were tested for HTLV-I/II infection on entry into the clinic, of whom 25 were infected with HTLV-I and 35 with HTLV-II. Multivariate analysis revealed that patients with coinfections were more likely to be black, aged over 35 years, and have a history of injection drug use. HIV-1/HTLV-I coinfections were associated with higher median CD8 counts on entry (p < 0.05), and HIV-1/HTLV-II coinfections were associated with higher median percent CD4 counts (p < 0.05) compared with patients infected with HIV only. Coinfection was not associated with an increased diagnosis of AIDS. These findings indicate that HIV-1/HTLV-I/II coinfections are frequently diagnosed and are associated with unique immune phenotypes. Given the lack of information regarding the influence of dual infection on clinical status, differentiation of HTLV-I from HTLV-II infections may be important in understanding the clinical significance of retroviral coinfections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989213     DOI: 10.1097/00042560-199701010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  5 in total

1.  HTLV-2 infection in injection drug users in King County, Washington.

Authors:  Joseph R Zunt; Ken Tapia; Hanne Thiede; Rong Lee; Holly Hagan
Journal:  Scand J Infect Dis       Date:  2006

Review 2.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

3.  Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.

Authors:  Upal Roy; Scott A Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L Winsor; Mark A Beilke
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

4.  Predictive factors of HTLV1-HIV coinfections in French Guiana.

Authors:  Elise Gouhier; Emilie Gaubert-Maréchal; Philippe Abboud; Pierre Couppié; Mathieu Nacher
Journal:  Am J Trop Med Hyg       Date:  2013-08-12       Impact factor: 2.345

Review 5.  Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection.

Authors:  Abelardo Q-C Araujo
Journal:  Pathogens       Date:  2020-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.